Delivery of a 10-fold lower dose of miR-103 mimic (0.7 mg kg−1) alternating with a 2 Gy dose fraction of radiation was sufficient to decrease tumour burden (Fig. 3d) concomitant with a significant decrease in CD31 area (Fig. 3e). The gene discussed is PECAM1; the disease is neoplasm.